Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transcriptomic profiling of tacrolimus vs mTOR inhibitors in renal transplant recipients
2013-004538-14Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Feb 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus, sirolimus and everolimus in kidney transplant (2 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Microarray-based gene expression profiling in PBMCs. Started Feb 2014; status: completed.
02
Drugs
tacrolimussirolimuseverolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2013-004538-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004538-14.